biguanides has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Sun, C | 1 |
| Huang, L | 1 |
| Liu, M | 1 |
| Li, L | 1 |
| Wang, X | 1 |
| Wang, L | 1 |
| Sun, S | 1 |
| Xu, H | 1 |
| Ma, G | 1 |
| Zhang, L | 1 |
| Zheng, J | 1 |
| Liu, H | 1 |
1 other study available for biguanides and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Magnolol-loaded cholesteryl biguanide conjugate hydrochloride nanoparticles for triple-negative breast cancer therapy.
Topics: Animals; Biguanides; Biphenyl Compounds; Cell Line, Tumor; Drug Carriers; Humans; Lignans; Mice; Nan | 2022 |